Prednisone Terminated Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00089856GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
NCT00024167Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
NCT00133224Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients